Tag Archives: data

Demographic Trends in People Receiving Covid-19 Vaccination in the United States | Instant News


The CDC is working with jurisdictions to provide more information on the demographic characteristics of vaccinated people.

These demographic data are representative of the geographic areas that contribute data and may differ according to the population prioritized in each jurisdiction’s vaccination phase. Therefore, these data may not be generalizable to the entire US population. The percentages shown in the chart below represent the percentage of people vaccinated in each age group.

Data will be updated as soon as it is reviewed and verified, often before 8:00 pm ET each day. However, daily updates may take longer if there are delays in data reporting.

Data on vaccine doses administered include data received by the CDC at 6:00 AM ET on the reporting day. Vaccination data on the CDC COVID Data Tracker is updated daily (including weekends) between 1:30 PM and 8:00 PM ET. Updates will be made the following day when reporting coincides with a federal holiday.

This data represents the subset of individuals in the jurisdictions (states, territories, and local entities) for which data has been reported. Demographic data includes people vaccinated through all parts of the program, including those vaccinated through pharmacies, the Federal Pharmaceutical Partnership Program for Long-Term Care (LTC), and federal entities.

Reported demographic data have varying degrees of data loss and cannot be generalized to the entire population of individuals who have received COVID-19 vaccination.

Missing data may be affected by inconsistent collection of information at the time of vaccination, differences in jurisdictional electronic data programs, and some jurisdictional policies or laws that do not allow demographic data to be reported.

Vaccinations by age group at the US level, visualized in two pictures:

Percentage by age group among people who received at least one dose of vaccine and
Percentage by age group among people who were fully vaccinated.
All reported numbers may change over time as historical data is reported to the CDC.

* Texas does not report age-specific dose number information to the CDC, so data for Texas is not represented in this figure.

Doses reported as given before the start of the national vaccination program on 12/14/2020 are not included in the figures but are included in the cumulative total of the total doses given in the CDC COVID Tracker.

Definition:

People who received at least one dose ** (previously “received 1 or more doses”) represent the total number of people who have received at least one dose of the vaccine.

Fully vaccinated people ** represent the number of people who received a second dose of a two-dose vaccine or a single-dose vaccine.

For reporting on the CDC COVID Data Tracer, the CDC counts people as “fully vaccinated” if they receive two doses on different days (regardless of time interval) of a two-dose mRNA series or receive a single dose of vaccine. Clinical Considerations While the current CDC is more specific than a COVID data tracker in two ways:

First, according to interim guidelines, the second dose of Pfizer-BioNTech and Moderna vaccines should be given as close as possible to the recommended intervals, but not earlier than the recommended (i.e., 3 weeks [Pfizer-BioNTech] or 1 month [Moderna]). However, a second dose given within a grace period of 4 days earlier than the recommended date for a second dose is still considered valid. If you cannot follow the recommended interval and delay in vaccination cannot be avoided, the second dose of Pfizer-BioNTech and Moderna COVID-19 vaccines can be given up to 6 weeks (42 days) after the first dose. At present, only limited data is available on the efficacy of the COVID-19 mRNA vaccine provided outside of this window.
Second, to ensure sufficient time for the immune response to occur, a person is considered to be fully vaccinated = 2 weeks after completing a two-dose mRNA series or a single dose of the Janssen Johnson & Johnson vaccine.
** The number of people who received at least one dose of vaccine and the number of people fully vaccinated was determined based on information reported to the CDC regarding dose number, vaccine manufacturer, date of administration, recipient ID, and date of delivery. Because the methods used to determine dosage amounts need to be applied in a variety of jurisdictions with different reporting practices, estimates of CDC dose counts may differ from those reported by jurisdictions and federal entities.

To calculate the national population estimate, the CDC uses, as a denominator, a combination of:

2019 National Census Population Estimates from the US Census Bureau Annual Estimates of Resident Population for the United States (including the District of Columbia [DC]) and Puerto Rico

(https: //www2.census….-2019/counties/)
and the 2018 CIA World Factbook for US territories and free-associated states (American Samoa, Federated States of Micronesia, Guam, Commonwealth of Northern Mariana Islands, Republic of Palau, Republic of the Marshall Islands, and US Virgin Islands).
To estimate the population 18+ and 65+ for the US region, the CDC assumes that the proportion of people 18 years and over and 65 and over in the region equals the total of the 50 states, DC, and Puerto Rico (78 % and 17%, respectively).
Emergency Use Authorization has been granted for use of the Pfizer-BioNTech vaccine among people aged 16 years and over and for use of Moderna vaccine and Johnson & Johnson Janssen vaccine (J & J / Janssen) among persons aged 18 years and over. on. Therefore, vaccine use is limited to those under 18 years of age.

.



image source

Great Britain to pilot COVID certificates for sporting events and nightclubs – POLITICO | Instant News


LONDON – Britain will begin piloting domestic COVID certificates this month, giving access to certain venues including sports stadiums and nightclubs, as ministers consider ways to reopen the post-lockdown UK economy.

People who have been vaccinated, received a negative test recently or have natural immunity after recovering from infection in the past six months, can attend trial events at sports venues, conference centers and nightclubs. That includes this month’s FA Cup semi-final and May’s final.

Businesses, including pubs and restaurants, which are allowed to reopen outdoors on April 12, and indoors on May 17, will not be asked to ask customers to prove their COVID status, Downing Street said. The hotel sector warned Prime Minister Boris Johnson that such a move would be unsuccessful and discriminatory when he pitched his idea last month.

The plans for a COVID certificate will be one of the details that Johnson will set out on Monday as part of a broader update on Britain’s route out of lockdown, which began last week with people allowed to meet outdoors in groups of six.

Returning to non-essential international travel on May 17 has not been ruled out, but Downing Street warned people may have to wait longer as some countries experience a third wave of the disease. The ministers also weighed the risks posed by the so-called “attention variant” that may be resistant to current vaccines. The country’s traffic light system will come into effect when restrictions are lifted.

There will be no isolation requirements for travel from countries in the new “green category” – although pre-departure and post-arrival tests are still required. The “red” and “yellow” restrictions will remain as they are, with conditions for quarantine or self-isolation when returning to the UK, Downing Street said in a press release explaining his thinking.

Meanwhile, Germany is also considering introducing a system that allows people to be vaccinated into shops, restaurants and hotels, Health Minister Jens Spahn told the Bild am Sonntag newspaper.

“Anyone who has been fully vaccinated can, in the future, be treated like someone who has tested negative,” said Spahn.

Germany is considering a rapid testing system to reopen its retail and hospitality sectors. New findings from the country’s infectious diseases agency, obtained by Bild, suggest the risk of transmission is so low two weeks after the second dose of vaccine that those who are fully inoculated can skip tests and quarantine to shop and travel.

The UK government has faced strong opposition in parliament over its plans for a domestic COVID certificate. More than 70 lawmakers, including more than 40 Conservative supporters of Johnson himself, oppose the so-called COVID passport in Britain.

Michael Gove, the Cabinet Office minister overseeing the certificate plan, said a COVID certificate would become “a necessity for international travel,” in an article for the Sunday Telegraph.

The European Commission has proposed so-called digital green certificates, which would permit travel across the block confirming vaccinations, immunity or coronavirus testing status.

Gove said the certificate could be “a valuable aid to opening up our domestic economy and society more quickly.”

The pilot event should be closed to the public until the end of this year without a certificate scheme, Gove said. He also warned businesses could start setting up their own private certification schemes to restrict access if the government doesn’t act.

“Unless the Government takes the lead, we run the risk of someone else setting the rules of the road. So where is the line to be drawn to help protect freedom, respect privacy, promote equality and return us to normalcy? And how can we ensure that our approach is proportionate. and limited time ?, “he wrote.

“Appropriate exceptions” for people who have been advised not to be vaccinated, or who cannot be repeatedly tested, are being examined, and the NHS is working on digital and non-digital certificates, Downing Street said.

Sarah Wheaton contributed reporting.

.



image source

Covid-19 coronavirus: How soon will the Pfizer vaccine be ready for children aged 12-15 years? | Instant News


Political

Watch: Covid-19 Response Minister Chris Hipkins receives first dose of Pfizer vaccine, as does Associate Health Minister Ayesha Verrall.

New Zealand may not be at the front of the queue for the data it needs before the Pfizer vaccine can be approved for children ages 12 to 15, the Health Ministry said.

The vaccine is currently approved by Medsafe for those aged 16 and over, but yesterday Pfizer and BioNTech released the results of their phase three clinical trial which demonstrated 100 percent efficacy for those aged 12 to 15 years.

Medsafe is expected to provide data on the trial in due time, a Health Ministry spokesman said, although New Zealand is not expected to be on the high priority list.

“It is likely they will prioritize countries with high levels of Covid-19 infection first,” said a ministry spokesman.

Extending vaccine approval to 12 to 15 year olds in New Zealand requires first an application from Pfizer.

“Medsafe needs to review the data to consider renewal approval,” said a ministry spokesman, adding that strict safety and efficacy standards had to be met.

The trials demonstrated a strong antibody response and tolerable side effects consistent with those seen in adults aged 16 to 25 years.

That includes 2,260 adolescents in the United States, with and without evidence of previous SARS-CoV-2 (the virus that causes the disease) infection. There were 18 cases of Covid-19 in the placebo group and none in the vaccinated group.

A strong antibody response was observed in most adolescents one month after the second dose.

Further clinical trials have started in children aged 5 to 11 years and are expected to start in children aged 2 to 5 years in early April, followed by ages six months to 2 years.

Vaccinating young people is considered important to achieve herd immunity. In New Zealand, more than 1 million people – 20 percent of the population – are under 16 years of age.

Covid-19 Response Minister Chris Hipkins receives first dose of Pfizer vaccine.  Photo / Mark Mitchell
Covid-19 Response Minister Chris Hipkins receives first dose of Pfizer vaccine. Photo / Mark Mitchell

Immunization Advisory Center Clinical Director Dr Nikki Turner said the trial results were “very promising”.

“Hopefully, with this promising looking data, we won’t go too far from being able to expand New Zealand’s Covid-19 immunization program to children as well.

“By doing so we will ensure more New Zealanders are protected individually and also, with more New Zealanders being vaccinated, the more we will be in a position to reduce the risk of community spread.”

Covid-19 Secretary Chris Hipkins, who received his first dose of vaccine this week, agrees the signs are encouraging, but they are “early days”.

Hipkins said the Government had ordered enough Pfizer stocks to get the vaccine to everyone in New Zealand – across all age groups.

“If not [get approved], our base is covered because of the wide portfolio we have. For example, AstraZeneca could prove to be the right vaccine for younger New Zealanders, or Novavax [or Janssen]. “

.



image source

Technical issues delayed the release of state COVID-19 data local | Instant News


HARRISBURG — Due to technical issues, no official COVID-19 data was released on Saturday or Sunday. The complete COVID-19 data for the weekend will be updated at noon today.

The Ministry of Health pointed out that the COVID Alert PA app may be displaying case data for the wrong weekend date. The most accurate COVID-19 data available is from Friday, March 26, and can be found on the “Pennsylvania COVID-19 Data” page.

Also on Friday, DOH announced the establishment of a free COVID-19 testing site in Central County and emphasized the need to continue testing, wear masks and maintain social distancing.

From March 30 (Tuesday) to May 1 (Saturday), the test will be provided at the State University Patton Plaza 100 Patton Township Municipal Building from 10 am to 7 pm every day.

Up to 450 people can be tested every day. PCR testing of mid-nasal swabs will be performed. The test is based on a first-come, first-served principle and is completely free. No appointment is required. Non-county residents can also take the test. Patients must be three years of age and older and do not need to show symptoms of COVID-19 to be tested. Encourage patients to bring photo ID or insurance cards. Registration will also be completed on site. The turnaround time for test results is two to seven days after the test.

In recent weeks, both Central County and Krefeld County have seen a significant increase in COVID-19 positive tests.

.



image source

The increase in the Transtasman bubble: A positive move as the number of infected Australian tourists is revealed | Instant News


The new data was greeted by experts as a positive step towards a transtasman bubble. Photo / 123RF

Emerging data shows only three people who traveled directly from Australia to New Zealand tested positive for Covid-19 for eight months.

This has been welcomed by experts as a positive step towards a transtasman bubble – but they say New Zealand needs to up its border game to Australian level to reduce the risk of creating a Covid-19 outbreak.

Data showing the three positive cases came through the Official Information Act request to the Ministry of Health seeking the number of positive cases of Covid-19 since March last year. That shows that there were 39 positive cases in March and April last year – then almost none.

One case was identified in August, one in November and another in January. NZ statistics show that during the same period 23,447 people traveled from Australia to New Zealand.

Otago University epidemiology professors Dr Nick Wilson and Dr Michael Baker support the data which add strength to the argument for the bubble but add a note of caution. Academics last year conducted research on alternative ways to manage incoming travelers.

READ MORE
This movement encourages the anti-vax theory of Covid-19
Covid-19 coronavirus: Four isolation hotels face law enforcement action over failure to keep staff safe
Covid 19 coronavirus: MIQ staff fired after bedroom meeting with returnees
The Wiggles is giving MIQ a venue for its upcoming national concert
Covid 19 coronavirus: More tourists are knowing about the MIQ mixing
The New Zealander at MIQ at Pullman illustrates the reality after a new case

Wilson said a “prudent” system was needed for quarantine-free travel between Australia and New Zealand.

It includes a development process so that every incoming Australian traveler is required to download a Ministry of Health app to scan a QR code, activate its bluetooth function and agree to use it at every opportunity during the first few weeks.

He said a saliva test at the airport would also reduce risks, as would a ban on attending large-scale events and conducting spot checks on travelers with fines for those who circumvent the rules.

“I hope they talk about these things now. The economic benefits are huge.

“In general, I would be more concerned with New Zealand border controls than Australia. We just have a loose process.”

He said quarantine rules in Australia offered a higher level of protection from the virus, including rules such as restricted arrivals in their rooms upon arrival. In New Zealand, areas of risk include bus travel for exercise, movement in MIQ facilities, smoking mingling in outdoor areas without masks, and other areas.

He said New Zealand’s approach had been locked in a “pathway dependency”, meaning the government was struggling to deviate from systems developed as the pandemic approached.

Wilson said the vaccination programs in both countries are also encouraging and as the percentage of the population being vaccinated has increased, so has the belief to free travel.

Professor Michael Baker (left) and Professor Nick Wilson.  Photo / Provided
Professor Michael Baker (left) and Professor Nick Wilson. Photo / Provided

Baker said the figures were “very supportive evidence” for the transtasman bubble. That’s not suggesting risk-free travel but a new system – as outlined by Wilson – could reduce risk to a manageable level.

“It’s never ‘without risk.’ There will always be risk. It’s about managing it successfully.”

He said he prefers to use the term “green zone” to identify low-risk countries, whereas those with high risk are in the “red zone”. He said a greater job in “red zone” countries managing those traveling to New Zealand would reduce the likelihood of border breaches.

“This is an opportunity to compare our borders with Australia. The world needs a model of success. This is a great opportunity to show a model that can be rolled out globally.”

Baker said those who travel should accept that outbreaks of the communities they visit can lead to being trapped there.

“That would be a trade-off – all travelers have to do this with their eyes open. Things can change very quickly.”

University of Auckland associate professor of microbiology Dr Siouxsie Wiles said the data showing the three infected travelers from Australia were encouraging.

“There’s always a complication that not everyone infects others – and some become super spreaders.”

Wiles said it was important for those traveling from Australia not to share planes with those transiting from other countries because of the possibility of contracting Covid-19 while flying.

He said one possible risk to manage was the opening up of space in MIQ and an increase in travelers from less safe countries.

Health Minister Chris Hipkins said he was aware of the figure and Australia was seen as a lower risk for origin cases, which is why so much work has led to the transtasman bubble.

“But as we have said before, low risk is not without risk. While we are always clear, we want to open this particular bubble as soon as we can, it will not happen until both countries feel equally comfortable with the risk.”

Hipkins said the time it takes to travel to Australia has reinforced New Zealand’s positioin for a “wider reopening of travel”, including issues such as insurance, a clear message for those who have to seek cover, and the impact on airlines and airports that face numbers. more passengers. arrival in the Covid-19 environment.

“Strengthening our position in terms of travel between here and Australia will help us set a sustainable pattern for the future.”

BusinessNZ chief executive Kirk Hope said there was a desire to bubble travel with Australia.

“But if those costs raise the alert level in Auckland, it’s a zero-sum game. The economic costs outweigh the benefits.”

Action Party leader David Seymour said questions remained about the quality of New Zealand’s border controls even as Australia had upgraded its system.

Seymour said New Zealand needed to stop seeing the world as having an equal risk around the world and develop a system that is responsive to the “hot spots” of Covid-19.

Until that happened, he said it echoed an Australian question: “New Zealand, where the hell are you bleeding?”

A Health Ministry spokesman said the data – along with other information – was being used to develop New Zealand’s response to Covid-19. “This includes potential travel bubbles and when this could occur.”

Data showing the three positive cases was collected through the ESR database based on people being asked about the last three countries in which they spent time.

.



image source